mometasone receives marketing approval in japan

1
Inpharma 1648 - 26 Jul 2008 Mometasone receives marketing approval in Japan for the treatment of allergic rhinitis in adults. Mometasone [Nasonex; Schering-Plough], an intranasal steroid, is currently approved in more than 100 counties worldwide. Schering-Plough Corporation. NASONEX(R) Now Approved in Japan for the Treatment of Allergic Rhinitis in Adult Patients. Media Release : 17 Jul 2008. Available from: URL: http://www.schering-plough.com 809091111 1 Inpharma 26 Jul 2008 No. 1648 1173-8324/10/1648-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Post on 09-Dec-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Mometasone receives marketing approval in Japan

Inpharma 1648 - 26 Jul 2008

■ Mometasone receives marketing approval in Japanfor the treatment of allergic rhinitis in adults.Mometasone [Nasonex; Schering-Plough], anintranasal steroid, is currently approved in more than100 counties worldwide.Schering-Plough Corporation. NASONEX(R) Now Approved in Japan for theTreatment of Allergic Rhinitis in Adult Patients. Media Release : 17 Jul 2008.Available from: URL: http://www.schering-plough.com 809091111

1

Inpharma 26 Jul 2008 No. 16481173-8324/10/1648-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved